HK1147773A1 - 西尼羅病毒疫苗及其生產方法 - Google Patents

西尼羅病毒疫苗及其生產方法

Info

Publication number
HK1147773A1
HK1147773A1 HK11101725.7A HK11101725A HK1147773A1 HK 1147773 A1 HK1147773 A1 HK 1147773A1 HK 11101725 A HK11101725 A HK 11101725A HK 1147773 A1 HK1147773 A1 HK 1147773A1
Authority
HK
Hong Kong
Prior art keywords
production
west nile
virus vaccine
nile virus
vaccine
Prior art date
Application number
HK11101725.7A
Other languages
English (en)
Inventor
Asato Kojima
Hidehiro Takahashi
Toyokazu Ishikawa
Original Assignee
Japan As Represented By The Director General Of Na
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By The Director General Of Na filed Critical Japan As Represented By The Director General Of Na
Publication of HK1147773A1 publication Critical patent/HK1147773A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK11101725.7A 2007-11-07 2011-02-22 西尼羅病毒疫苗及其生產方法 HK1147773A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007290169 2007-11-07
PCT/JP2008/070354 WO2009060961A1 (ja) 2007-11-07 2008-11-07 ウエストナイルウイルスワクチンおよびその製造方法

Publications (1)

Publication Number Publication Date
HK1147773A1 true HK1147773A1 (zh) 2011-08-19

Family

ID=40625846

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101725.7A HK1147773A1 (zh) 2007-11-07 2011-02-22 西尼羅病毒疫苗及其生產方法

Country Status (9)

Country Link
US (2) US8795687B2 (zh)
EP (1) EP2221368B1 (zh)
JP (1) JP5448836B2 (zh)
CN (1) CN101855349A (zh)
AU (1) AU2008325537B2 (zh)
CA (1) CA2704556A1 (zh)
HK (1) HK1147773A1 (zh)
SG (1) SG188127A1 (zh)
WO (1) WO2009060961A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102183637A (zh) * 2011-01-25 2011-09-14 中国检验检疫科学研究院 检测人西尼罗病毒IgG抗体的间接ELISA试剂盒及其检测方法
BR112019001461A2 (pt) * 2016-07-27 2019-05-07 Hawaii Biotech Inc. gene de envelope optimizado do zika vírus e expressão do mesmo
RU2642312C1 (ru) * 2016-09-20 2018-01-24 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ профилактики и лечения опасных нейровирусных инфекций
CN106754982B (zh) * 2016-12-14 2021-03-09 中国农业科学院哈尔滨兽医研究所 表达绿色荧光蛋白的限制性复制西尼罗病毒系统及其应用
CN108950086A (zh) * 2018-08-29 2018-12-07 浙江国际旅行卫生保健中心（浙江出入境检验检疫局口岸门诊部） 基于raa荧光法检测西尼罗病毒的引物探针组及检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2554254T3 (es) * 2000-02-16 2015-12-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Quimeras del virus del dengue 2 inmunógenas
US6733994B2 (en) * 2000-10-04 2004-05-11 The Trustees Of The University Of Pennsylvania Highly expressible genes
US7390495B2 (en) * 2001-04-04 2008-06-24 Institut Pasteur Neurovirulent strain of the West Nile virus and uses thereof
JP4268384B2 (ja) 2002-08-07 2009-05-27 財団法人阪大微生物病研究会 日本脳炎ウイルス抗原及びその製造方法
EP1454988A1 (en) * 2003-03-03 2004-09-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins
US20080118528A1 (en) 2004-05-04 2008-05-22 Tsanyang Jake Liang Synthesis and Purification of West Nile Virus Virus-Like Particles
WO2007103565A2 (en) 2006-03-09 2007-09-13 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Wnv dna vaccine incorporating a cmv/r backbone and expressing wnv prm and e proteins

Also Published As

Publication number Publication date
US8795687B2 (en) 2014-08-05
SG188127A1 (en) 2013-03-28
EP2221368A4 (en) 2010-11-24
WO2009060961A1 (ja) 2009-05-14
JPWO2009060961A1 (ja) 2011-03-24
EP2221368A1 (en) 2010-08-25
EP2221368B1 (en) 2014-03-26
AU2008325537A1 (en) 2009-05-14
CA2704556A1 (en) 2009-05-14
JP5448836B2 (ja) 2014-03-19
US20100247559A1 (en) 2010-09-30
AU2008325537B2 (en) 2014-07-24
CN101855349A (zh) 2010-10-06
US20140065180A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
PL2200646T3 (pl) Szczepionki RNA
EP2449000A4 (en) COMPOSITION AND PROCESS FOR PREPARING CURABLE ORGANOFLUORINE-MODIFIED POLYSILAZANS, AND POLYSILAZANS PREPARED THEREBY
HK1121757A1 (en) Pyrroloazacyclic derivatives, preparing method and use thereof
EP1984405A4 (en) INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
IL204361A (en) A method for producing influenza virus and influenza vaccine obtained from use of said method
BRPI1011592A2 (pt) "composição, e, método para fazer manutenção em um furo de poço."
HK1143328A1 (en) Method for producing viral vaccines
IL193397A0 (en) Hpv antigens, vaccine compositions, and related methods
IL200588A0 (en) Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
EP2351581A4 (en) VACCINE COMPOSITION AGAINST MALE AND CLAUSE DISEASE AND PREPARATION METHOD THEREFOR
EP2516512A4 (en) PROCESS FOR THE PREPARATION OF CURABLE POLYSILAZANES STABLE FOR PRESERVATION, AND POLYSILAZANS THUS PREPARED
PL2261014T3 (pl) Urządzenie formujące, jego klocek oraz sposób formowania
EP2152301A4 (en) TRYPANOSOME ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
EP1862537A4 (en) COMPOUNDS CULTIVATABLE CELLS WITHOUT ANIMALS, METHODS FOR THEIR REALIZATION, METHOD FOR PRODUCING VIRUSES USING THE CELL LINE AND IMPACT PRODUCTION PROCESS
BRPI0919485A2 (pt) vacinas, antígenos, composições de plasmodium e métodos
EP2481571A4 (en) GLASS, METHOD FOR PRODUCING THE SAME, AND LUMINESCENT DEVICE
HK1147773A1 (zh) 西尼羅病毒疫苗及其生產方法
EP2491946A4 (en) ADJUVANT FOR VACCINES, VACCINES COMPRISING SAME, AND USES THEREOF
EP2365071A4 (en) PROCESSED SOY PLANT WHICH STORES A VACCINE, AND USE THEREOF
EP2408000A4 (en) GLASS LUMINOUS ELEMENT, PREPARATION METHOD THEREOF, AND LUMINESCENCE METHOD USING THE SAME
IL238819A0 (en) Compositions, methods and uses for inducing viral growth
EP2481570A4 (en) GLASS, METHOD FOR PRODUCING THE SAME, AND LUMINESCENT DEVICE
EP2054081A4 (en) VACCINE AGAINST THE JC VIRUS
EP2481576A4 (en) LUMINESCENT GLASS, METHOD OF PRODUCTION AND LUMINESCENCE DEVICE
EP2398038A4 (en) LUMINESCENT GLASS ELEMENT, METHOD OF PRODUCTION AND METHOD OF LUMINESCENCE USING THE ELEMENT

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171107